Composition for treating a dermal anomaly
OwnerLindsey Berkson, Kenneth G. Burtoninventors
Life of this patent
Estimating the term…
Abstract
An improved composition for treatment of ulcer-type skin conditions. The composition is primarily characterized by a combination of nitroglycerin and arginine. Other embodiments comprise emollient cream, mineral oil, tumeric powder, folic acid, vitamin B12, and zinc citrate. The composition is particulary effective in improving blood flow in the underlying capillary bed about the wound, improving nerve growth about the wound, increasing circulation, and having a standardized and more predictable therapeutic characteristic.
Claims2
An injectable composition for treating a dermal anomaly comprising:
- approximately ten parts nitroglycerin;
- approximately ten parts arginine;
- approximately two parts lidocaine;
- approximately two parts zinc citrate;
- approximately 0.02 parts vitamin B12;
- and
- approximately 0.03 parts folic acid;
- wherein the injectable composition is for treating a dermal anomaly.
A topical composition for treating a dermal anomaly comprising:
- approximately 100 parts emollient cream base;
- approximately ten parts nitroglycerin;
- approximately ten parts arginine;
- approximately one quarter part turmeric;
- approximately two parts lidocaine;
- approximately two parts zinc citrate;
- approximately 0.02 parts vitamin B12;
- approximately 0.03 parts folic acid;
- and
- mineral oil;
- wherein the topical composition is for treating a dermal anomaly.
Dependencies are inferred from the claim text.